IL149585A0 - Process for the preparation of arylethanolamine derivatives having anti-obesity and anti-diabetic properties - Google Patents

Process for the preparation of arylethanolamine derivatives having anti-obesity and anti-diabetic properties

Info

Publication number
IL149585A0
IL149585A0 IL14958500A IL14958500A IL149585A0 IL 149585 A0 IL149585 A0 IL 149585A0 IL 14958500 A IL14958500 A IL 14958500A IL 14958500 A IL14958500 A IL 14958500A IL 149585 A0 IL149585 A0 IL 149585A0
Authority
IL
Israel
Prior art keywords
preparation
obesity
diabetic properties
arylethanolamine derivatives
arylethanolamine
Prior art date
Application number
IL14958500A
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IL149585A0 publication Critical patent/IL149585A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Glass Compositions (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
IL14958500A 1999-12-11 2000-12-08 Process for the preparation of arylethanolamine derivatives having anti-obesity and anti-diabetic properties IL149585A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9929297.1A GB9929297D0 (en) 1999-12-11 1999-12-11 Process
PCT/GB2000/004697 WO2001042195A1 (en) 1999-12-11 2000-12-08 Process for the preparation of arylethanolamine derivatives having an anti-obesity and anti-diabetic properties

Publications (1)

Publication Number Publication Date
IL149585A0 true IL149585A0 (en) 2002-11-10

Family

ID=10866125

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14958500A IL149585A0 (en) 1999-12-11 2000-12-08 Process for the preparation of arylethanolamine derivatives having anti-obesity and anti-diabetic properties

Country Status (23)

Country Link
US (1) US6548523B2 (de)
EP (1) EP1235788B1 (de)
JP (1) JP4903964B2 (de)
KR (1) KR100683614B1 (de)
CN (1) CN1224609C (de)
AT (1) ATE292110T1 (de)
AU (1) AU769387B2 (de)
BR (1) BRPI0016187B1 (de)
CA (1) CA2394117C (de)
CZ (1) CZ303143B6 (de)
DE (1) DE60019157T2 (de)
ES (1) ES2236020T3 (de)
GB (1) GB9929297D0 (de)
HK (1) HK1045988B (de)
HU (1) HU229043B1 (de)
IL (1) IL149585A0 (de)
NO (1) NO323239B1 (de)
NZ (1) NZ518795A (de)
PL (1) PL200540B1 (de)
PT (1) PT1235788E (de)
TR (1) TR200201528T2 (de)
WO (1) WO2001042195A1 (de)
ZA (1) ZA200204585B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10230147A1 (de) * 2001-10-09 2004-01-15 Profos Ag Verfahren zur unspezifischen Anreicherung von Bakterienzellen
US7158049B2 (en) * 2003-03-24 2007-01-02 Schlumberger Technology Corporation Wireless communication circuit
US8213085B2 (en) * 2008-01-18 2012-07-03 Visera Technologies Company Limited Image sensor device with high photosensitivity
US8778998B2 (en) 2009-04-10 2014-07-15 Auspex Pharmaceuticals, Inc. Biphenyl-3-carboxylic acid modulators of beta-3-adrenoreceptor
US9907767B2 (en) 2010-08-03 2018-03-06 Velicept Therapeutics, Inc. Pharmaceutical compositions and the treatment of overactive bladder
MX353105B (es) 2010-08-03 2017-12-19 Velicept Therapeutics Inc Combinaciones de agonistas del receptor beta-3-adrenergico y antagonistas del receptor muscarinico para tratar vejiga hiperactiva.
AU2013216864A1 (en) 2012-02-09 2014-09-11 Altherx, Inc. Combination of muscarinic receptor antagonists and beta- 3 adrenoceptor agonists for treating overactive bladder
KR20170086659A (ko) 2014-12-03 2017-07-26 벨리셉트 테라퓨틱스, 인크. 하부 요로 증상을 위한 변형 방출형 솔라베그론을 이용한 조성물 및 방법
CN108290824B (zh) 2015-10-23 2022-03-11 B3Ar治疗股份有限公司 索拉贝隆两性离子及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1551260A (en) 1976-02-09 1979-08-30 Allen & Hanburys Ltd Phenylethanolamine derivatives
JP2577222B2 (ja) * 1987-04-10 1997-01-29 興和株式会社 新規な置換アニリド誘導体
NO179246C (no) * 1991-11-20 1996-09-04 Sankyo Co Aromatiske amino-alkoholderivater og mellomprodukter til fremstilling derav
GB9525121D0 (en) 1995-12-08 1996-02-07 Glaxo Group Ltd Chemical compounds
BR9910092A (pt) * 1998-05-01 2002-01-22 Abbott Lab Inibidores de beta-aminoácido substituìdo de metionina aminopeptidase-2
GB9812709D0 (en) * 1998-06-13 1998-08-12 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
ES2236020T3 (es) 2005-07-16
JP4903964B2 (ja) 2012-03-28
NO20022758D0 (no) 2002-06-10
HUP0203640A3 (en) 2003-08-28
WO2001042195A1 (en) 2001-06-14
EP1235788A1 (de) 2002-09-04
TR200201528T2 (tr) 2002-09-23
CN1224609C (zh) 2005-10-26
CZ303143B6 (cs) 2012-05-02
CA2394117C (en) 2011-10-04
DE60019157T2 (de) 2006-02-02
PT1235788E (pt) 2005-08-31
CN1409700A (zh) 2003-04-09
KR100683614B1 (ko) 2007-02-16
GB9929297D0 (en) 2000-02-02
HU229043B1 (hu) 2013-07-29
EP1235788B1 (de) 2005-03-30
PL356483A1 (en) 2004-06-28
BR0016187A (pt) 2002-08-13
NO20022758L (no) 2002-07-01
NZ518795A (en) 2004-02-27
KR20020061636A (ko) 2002-07-24
CA2394117A1 (en) 2001-06-14
US6548523B2 (en) 2003-04-15
JP2003516383A (ja) 2003-05-13
PL200540B1 (pl) 2009-01-30
ZA200204585B (en) 2003-12-31
NO323239B1 (no) 2007-02-05
US20020198220A1 (en) 2002-12-26
BRPI0016187B1 (pt) 2016-08-02
CZ20022017A3 (cs) 2003-01-15
AU2191101A (en) 2001-06-18
AU769387B2 (en) 2004-01-22
HUP0203640A2 (hu) 2003-02-28
HK1045988B (zh) 2005-07-15
ATE292110T1 (de) 2005-04-15
DE60019157D1 (de) 2005-05-04
HK1045988A1 (en) 2002-12-20

Similar Documents

Publication Publication Date Title
HU0101336D0 (en) Process for the preparation of perindopril and their pharmaceutically acceptable salts
BG101250A (en) Salts of an anti-migraine indole derivative
GB9914486D0 (en) Medicaments
ES2052452A1 (es) Procedimiento de preparacion de inhibidores duales de no-sintasa y ciclooxigenasa.
CY1106743T1 (el) Μεθοδος παρασκευης θειαμεθοξαμης
IL149585A0 (en) Process for the preparation of arylethanolamine derivatives having anti-obesity and anti-diabetic properties
WO2002072009A3 (en) Heterocyclic derivatives for the treatment of cancer and other proliferative diseases
MY123908A (en) Meta-azacyclic amino benzoic acid compounds and derivatives thereof
ATE230740T1 (de) Piperidinylpyrimidine derivate
IL108695A (en) Pharmaceutical composition comprising polyamine derivatives and some such novel compounds
AU2001274806A1 (en) Sulfonamide derivatives
HUP0105308A2 (hu) Eletriptán-hidrobromid-monohidrát, eljárás az előállítására és a vegyületet tartalmazó gyógyszerkészítmények
IL130324A0 (en) Pharmaceutical compositions comprising iron chelators for the treatment of neurodegenerative disorders and some novel iron chelators
EP0399519A3 (de) Verwendung von Polyaminderivaten zur Verstärkung der zellularen Immunität
UA66866C2 (uk) Синтез морфолінових похідних
HK1053109A1 (en) Substituted homopiperidinyl benzimidazole compounds, pharmaceutical compositions comprising the same, methods for preparing them and the use for the preparation of a medicament of them
GB0012526D0 (en) Triterpenoid derivatives
HK1040237A1 (en) Fused polycyclic amino acids as pharmaceutical agents.
AP1518A (en) Novel octahydro-6, 10-dioxo-6h-pyridazino/1,2-a/ /1,2/diazepin-1-carboxylic acid derivatives, preparation method and use for preparing therapeutically active compounds.
IL113341A0 (en) Pharmaceutical compositions comprising antimigraine compounds and their preparation
AU2001258631A1 (en) Triterpenoid derivatives
BG104964A (en) Improved method for preparing pharmaceutically valuable norbenzomorphane derivatives
EP1445262A8 (de) Peptidderivat, pharmazeutisch unbedenkliches salz davon, verfahren zu dessen herstellung und dessen verwendung
ZA994817B (en) 8H-thieno-[2,3-b]pyrrolizin-8-one compounds, a process for their preparation and pharmaceutical compositions containing them.
JO2301B1 (en) Method for the preparation of stabilizer Neuraminides R-OH-64-796

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees